Abstract
Background:
Fibroblast growth factor 8 (FGF8) is over-expressed in prostate cancer (CaP) correlating with high-grade disease and reduced survival. The role of acetylation in transcriptional regulation of FGF8 was investigated using the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA).
Methods:
FGF8 transcriptional response to TSA was investigated by gene reporter assays, RT-PCR, and Western blotting. Chromatin immunoprecipitation (ChIP) assays were also performed.
Results:
FGF8 is upregulated in response to TSA treatment along with NF-kappaB transcriptional activity. Over-expression of p65 activated FGF8 transcription. ChIP assays revealed p65 recruitment to the fgf8 promoter, containing putative NF-kappaB binding sites, post TSA stimulation. PI-3K activity is required for TSA mediated FGF8 upregulation.
Conclusion:
Using TSA treatment in prostate cancer cells, a requirement of PI-3K activity in mediating TSA function is demonstrated and a novel role for NF-kappaB in the regulation of FGF8 expression is uncovered.
(c) 2006 Wiley-Liss, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylation
-
Base Sequence
-
Binding Sites
-
Blotting, Western
-
Cell Line, Tumor
-
Chromatin
-
DNA / chemistry
-
DNA / metabolism
-
Enzyme Inhibitors / pharmacology
-
Fibroblast Growth Factor 8 / analysis
-
Fibroblast Growth Factor 8 / genetics*
-
Gene Expression Regulation, Neoplastic* / drug effects
-
Histone Deacetylase Inhibitors
-
Humans
-
Hydroxamic Acids / pharmacology
-
Immunosorbent Techniques
-
Male
-
Molecular Sequence Data
-
NF-kappa B / metabolism
-
NF-kappa B / physiology*
-
Phosphatidylinositol 3-Kinases / metabolism
-
Polymerase Chain Reaction
-
Promoter Regions, Genetic / genetics
-
Prostatic Neoplasms / chemistry
-
Prostatic Neoplasms / genetics*
-
Prostatic Neoplasms / metabolism
-
Recombinant Fusion Proteins
-
Reverse Transcriptase Polymerase Chain Reaction
-
Transcription Factor RelA / metabolism
-
Transcription, Genetic
-
Transfection
-
Up-Regulation
Substances
-
Chromatin
-
Enzyme Inhibitors
-
FGF8 protein, human
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
NF-kappa B
-
RELA protein, human
-
Recombinant Fusion Proteins
-
Transcription Factor RelA
-
Fibroblast Growth Factor 8
-
trichostatin A
-
DNA
-
Phosphatidylinositol 3-Kinases